These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32627939)

  • 21. Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).
    Clerkin KJ; Garan AR; Wayda B; Givens RC; Yuzefpolskaya M; Nakagawa S; Takeda K; Takayama H; Naka Y; Mancini DM; Colombo PC; Topkara VK
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridge with a left ventricular assist device to a simultaneous heart and kidney transplant: Review of the United Network for Organ Sharing database.
    Gaffey AC; Chen CW; Chung J; Grandin EW; Porrett PM; Acker MA; Atluri P
    J Card Surg; 2017 Mar; 32(3):209-214. PubMed ID: 28176387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular Assist Device Technology and Black-White Disparities on the Heart Transplant Wait List.
    Frech A; Tarrence J; Natale G; Tumin D
    Prog Transplant; 2021 Mar; 31(1):80-87. PubMed ID: 33353482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marginal Improvement in Survival Post-Heart Transplantation in Patients With Prior Left Ventricular Assist Device: A Temporal Analysis of United Network of Organ Sharing Registry.
    Pal N; Stansfield J; Mukhopadhyay N; Nelson M
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):392-400. PubMed ID: 31679997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial disparity exists in the utilization and post-transplant survival benefit of ventricular assist device support in children.
    Greenberg JW; Bryant R; Villa C; Fields K; Fynn-Thompson F; Zafar F; Morales DLS
    J Heart Lung Transplant; 2023 May; 42(5):585-592. PubMed ID: 36710094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
    Cogswell R; Duval S; John R
    Int J Cardiol; 2018 Oct; 268():51-54. PubMed ID: 29803342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices.
    Yoshioka D; Li B; Takayama H; Garan RA; Topkara VK; Han J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):918-924. PubMed ID: 29106559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation.
    Taghavi S; Jayarajan SN; Komaroff E; Mangi AA
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1966-71, 1971.e1. PubMed ID: 24613158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waitlist and transplant outcomes in heart transplant candidates bridged with temporary endovascular right ventricular assist devices.
    Kwon JH; Skidmore SH; Bhandari K; Carnicelli AP; Yourshaw JP; Shorbaji K; Kilic A
    J Heart Lung Transplant; 2024 Mar; 43(3):369-378. PubMed ID: 37951321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Continuous-Flow Left Ventricular Assist Device Duration on Postoperative Outcomes.
    Chauhan D; Okoh AK; Haik N; Kang N; Choi M; Baran D; Zucker M; Camacho M; Russo MJ
    Ann Thorac Surg; 2017 Dec; 104(6):1933-1938. PubMed ID: 28964413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis.
    Alba AC; Kirklin JK; Cantor RS; Deng L; Ross HJ; Jacobs JP; Rao V; Hanff TC; Stehlik J
    J Heart Lung Transplant; 2023 Nov; 42(11):1587-1596. PubMed ID: 37385418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.